Research contributor
Professor of Medicine; Co-Director, Center for Drug Safety and Effectiveness; Director, Pharmacoepidemiology Program
Johns Hopkins Medicine
Drug-safety research lens
Her documented work spans drug safety, pharmacoepidemiology, comparative effectiveness, and general internal medicine.
- Drug safety
- Reflected in her leadership of the Center for Drug Safety and Effectiveness.
- Pharmacoepidemiology
- The program she directs at Johns Hopkins.
- Comparative effectiveness
- A documented part of her clinician-investigator work.
- General internal medicine
- Her clinical discipline in the supplied source record.
Comparative evidence perspective
Jodi Segal, MD, MPH, is a Professor of Medicine at Johns Hopkins, Co-Director of the Center for Drug Safety and Effectiveness and Director of the Pharmacoepidemiology Program. She is a general internist and an internationally recognized clinician-investigator in comparative effectiveness and drug safety, and a Fellow of the American College of Physicians.
Research leadership and training
Clinical and academic roles
Board-certified internist (ABIM, 1997) and clinical epidemiologist; Professor of Medicine, Johns Hopkins, with joint appointments in Health Policy and Management and in Epidemiology; Co-Director, Center for Drug Safety and Effectiveness; Director, Pharmacoepidemiology Program.
Education and training
- BS, Pennsylvania State University
- MD, University of Pittsburgh School of Medicine, 1994
- MPH, Johns Hopkins Bloomberg School of Public Health
- Residency, Internal Medicine, University of Chicago Medicine, 1997
- Fellowship, General Internal Medicine, Johns Hopkins, 2000
- Board certification, Internal Medicine, ABIM, 1997
Evidence behind the profile
The Johns Hopkins provider record confirms her appointments, while the publication search provides the research trail.